DexCom Inc. (NASDAQ:DXCM) stock is trading higher on Monday after the diabetes management company reported positive results from its CONNECT randomized controlled trial.
On Saturday, the study showed that use of the Dexcom G7 continuous glucose monitoring (CGM) system led to clinically and statistically significant reductions in A1C and improved glucose control among adults with Type 2 diabetes who are not using insulin.
Researchers also observed additional A1C reductions when Dexcom G7 was used alongside standard diabetes treatments, including metformin, GLP-1 therapies, and SGLT2 inhibitors.
Key Findings From The CONNECT Trial
Participants using Dexcom G7 recorded an average A1C reduction of 1.6% from a baseline mean A1C of 8.8%, representing a 0.9% greater decline than the control group.
Among participants with starting A1C levels above 10%, the average reduction reached 3.1%, exceeding the control group by 2.1%.
Additionally, 82% of Dexcom G7 users achieved at least a 0.5% reduction in A1C. By week 26, 68% of participants reached an A1C below 7.5%, while 46% achieved levels below 7.0%.
Improved Time In Range And Patient Satisfaction
The study also showed meaningful improvements in glucose management. Participants using Dexcom G7 spent an average of five additional hours per day within the target glucose range of 70 to 180 mg/dL compared with the control group.
Improvements appeared within the first four weeks and were maintained throughout the study.
At the end of 26 weeks, Dexcom G7 users averaged 62% time in range versus 41% for those receiving routine care.
Participants also reported greater satisfaction with CGM use, lower diabetes-related distress, and reduced disease burden. Median daily use of the device reached 97% during the trial.
A six-month extension phase is underway to evaluate whether the observed benefits can be sustained for up to 12 months.
DXCM Stock Price Activity: DexCom shares were up 5.45% at $76.83 at the time of publication on Monday, according to Benzinga Pro data.
Photo: Photo Nature Travel / Shutterstock.com
Recent Comments